Personalized Tasty&Healthy whole-food diet for maintaining remission in children and adults with Crohn's disease: results from the MyTasty open-label trial

被引：0
|
作者：
Plotkin, L. [1 ,2 ]
Frutkoff, Y. Aharoni [1 ]
Shavit, Z. [1 ]
Focht, G. [1 ]
Livovsky, J. [1 ]
Buchuk, R. [1 ]
Lev-Zion, R. [1 ]
Ledder, O. [1 ]
Assa, A. [1 ]
Boneh, R. Sigall [3 ]
Weiss, B. [4 ]
Slae, M. [5 ]
Dotan, I [6 ]
Kierkus, J. [7 ]
Broide, E. [8 ]
Griffiths, A. [9 ]
Naftali, T. [10 ]
Aloi, M. [11 ]
Yerushalmy-Feler, A. [12 ]
Schwerd, T. [13 ]
Reifen, R. [2 ]
Turner, D. [1 ]
机构：
[1] Shaare Zedek Med Ctr, Juliet Keidan Inst Pediat Gastroenterol & Nutr, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Inst Biochem Food Sci, Nutr Robert H Smith Fac Agr Food & Environm, Rehovot, Israel
[3] E Wolfson Med Ctr, Pediat Gastroenterol & Nutr Unit, Holon, Israel
[4] Sheba Med Ctr, Pediat Gastroenterol, Ramat Gan, Israel
[5] Pediat Gastroenterol Ctr, Hadassah Ein Kerem, Jerusalem, Israel
[6] Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[7] Childrens Mem Hlth Inst, Pediat Gastroenterol Unit, Warsaw, Poland
[8] Assaf Harofeh Med Ctr, Pediat Gastroenterol Unit, Zerifin, Israel
[9] Hosp Sick Children, Pediat Gastroenterol, Toronto, ON, Canada
[10] Meir Hosp, Gastroenterol, Kefar Sava, Israel
[11] Sapienza Univ Rome, Dept Pediat Gastroenterol, Rome, Italy
[12] Tel Aviv Sourasky Med Ctr, Pediat Gastroenterol, Tel Aviv, Israel
[13] LMU Munchen, Dr Hauner Childrens Hosp, Munich, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1267
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1093
引用
收藏
页码：i2009 / i2010
页数：2
相关论文
共 50 条
  • [21] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [22] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [23] Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) a pragmatic, open-label, non-inferiority, randomised controlled trial
    van Linschoten, Reinier C. A.
    Jansen, Fenna M.
    Pauwels, Renske W. M.
    Smits, Lisa J. T.
    Atsma, Femke
    Kievit, Wietske
    de Jong, Dirk J.
    de Vries, Annemarie C.
    Boekema, Paul J.
    West, Rachel L.
    Bodelier, Alexander G. L.
    Gisbertz, Ingrid A. M.
    Wolfhagen, Frank H. J.
    Romkens, Tessa E. H.
    Lutgens, Maurice W. M. D.
    van Bodegraven, Adriaan A.
    Oldenburg, Bas
    Pierik, Marieke J.
    Russel, Maurice G. V. M.
    de Boer, Nanne K.
    Mallant-Hent, Rosalie C.
    ter Borg, Pieter C. J.
    van der Meulen-de Jong, Andrea E.
    Jansen, Jeroen M.
    Jansen, Sita, V
    Tan, Adrianus C. I. T. L.
    van der Woude, C. Janneke
    Hoentjen, Frank
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 343 - 355
  • [24] Natalizumab maintains corticosteroid-free remission for 2 years in patients with moderately to severely active crohn's disease and in those with prior infliximab exposure: Results from an open-label extension study
    Ghosh, S.
    Panaccione, R.
    GUT, 2007, 56 : A22 - A22
  • [25] Memantine Treatment in Patients with Alzheimer's Disease: Neuropsychological Results from an Open-Label, Multi-Center Brain Imaging Trial
    Saxton, Judith
    Hofbauer, Robert K.
    Graham, Stephen
    Yu, Sung Yun
    Li, Shaoyi
    Hsu, Hai-An
    Perhach, James L.
    NEUROLOGY, 2009, 72 (11) : A382 - A383
  • [26] Memantine Treatment in Patients with Alzheimer's Disease: Neuropsychological Results from an Open-Label, Multi-Center Brain Imaging Trial
    Hofbauer, Robert K.
    Graham, Stephen M.
    Saxton, Judith
    Yu, Sung Y.
    Li, Shaoyi
    Hsu, Hai-An
    Perhach, James L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A79 - A80
  • [27] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2001 - 2010
  • [28] Long-term efficacy and safety of mirikizumab treatment for Crohn's Disease: Results from the VIVID-2 open-label extension study
    Vermeire, S.
    Sands, B. E.
    D'Haens, G.
    Hisamatsu, T.
    Kelly, C. R.
    Lu, N.
    Morris, N.
    Moses, R.
    Durand, F.
    Protic, M.
    Hozak, R. R.
    Lopes, M. U.
    Regueiro, M.
    Laharie, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i87 - i89
  • [29] Results of a prospective, open-label trial - efficacy, safety and immunogenicity of Wilate® in children under 6 years of age with inherited von Willebrand's disease
    Nowak-Goettl, U.
    Kruempel, A.
    Russo, A.
    Jansen, M.
    Knaub, S.
    HAEMOPHILIA, 2011, 17 (02) : 357 - 357
  • [30] Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease: Results from an Open-Label, Phase I Trial
    Muramatsu, Shin-Ichi
    Fujimoto, Ken-Ichi
    Kato, Seiya
    Asari, Sayaka
    Mizukami, Hiroaki
    Ikeguchi, Kunihiko
    Kawakami, Tadataka
    Urabe, Masashi
    Kume, Akihiro
    Sato, Toshihiko
    Watanabe, Eiju
    Ozawa, Keiya
    Nakano, Imaharu
    MOLECULAR THERAPY, 2009, 17 : S168 - S168
12345